688 related articles for article (PubMed ID: 20448207)
1. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
5. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by exenatide: A novel mechanism via improving mitochondrial function involving the GLP-1 receptor/cAMP/PKA pathway.
Chang G; Liu J; Qin S; Jiang Y; Zhang P; Yu H; Lu K; Zhang N; Cao L; Wang Y; Li Y; Zhang D
Int J Mol Med; 2018 Mar; 41(3):1693-1703. PubMed ID: 29286061
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 protects endothelial cells from lipoapoptosis by PKA, PI3K, eNOS, p38 MAPK, and JNK pathways.
Erdogdu O; Eriksson L; Xu H; Sjöholm A; Zhang Q; Nyström T
J Mol Endocrinol; 2013 Apr; 50(2):229-41. PubMed ID: 23343509
[TBL] [Abstract][Full Text] [Related]
8. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
Sangle GV; Lauffer LM; Grieco A; Trivedi S; Iakoubov R; Brubaker PL
Endocrinology; 2012 Feb; 153(2):564-73. PubMed ID: 22186413
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor.
Erdogdu O; Nathanson D; Sjöholm A; Nyström T; Zhang Q
Mol Cell Endocrinol; 2010 Aug; 325(1-2):26-35. PubMed ID: 20452396
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
Hausenloy DJ; Whittington HJ; Wynne AM; Begum SS; Theodorou L; Riksen N; Mocanu MM; Yellon DM
Cardiovasc Diabetol; 2013 Oct; 12():154. PubMed ID: 24148218
[TBL] [Abstract][Full Text] [Related]
12. Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence.
Zhou T; Zhang M; Zhao L; Li A; Qin X
Am J Physiol Cell Physiol; 2016 Oct; 311(4):C572-C582. PubMed ID: 27488664
[TBL] [Abstract][Full Text] [Related]
13. The Neuroprotective Effect of Liraglutide is Mediated by Glucagon-Like Peptide 1 Receptor-Mediated Activation of cAMP/PKA/CREB Pathway.
Bao Y; Jiang L; Chen H; Zou J; Liu Z; Shi Y
Cell Physiol Biochem; 2015; 36(6):2366-78. PubMed ID: 26279440
[TBL] [Abstract][Full Text] [Related]
14. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Ban K; Kim KH; Cho CK; Sauvé M; Diamandis EP; Backx PH; Drucker DJ; Husain M
Endocrinology; 2010 Apr; 151(4):1520-31. PubMed ID: 20172966
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH
J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430
[TBL] [Abstract][Full Text] [Related]
17. Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner.
Khedr RM; Ahmed AAE; Kamel R; Raafat EM
Life Sci; 2018 Oct; 211():31-39. PubMed ID: 30195035
[TBL] [Abstract][Full Text] [Related]
18. Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric-oxide synthase-dependent mechanism.
Ishii M; Shibata R; Kondo K; Kambara T; Shimizu Y; Tanigawa T; Bando YK; Nishimura M; Ouchi N; Murohara T
J Biol Chem; 2014 Sep; 289(39):27235-27245. PubMed ID: 25100725
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway.
Hui H; Nourparvar A; Zhao X; Perfetti R
Endocrinology; 2003 Apr; 144(4):1444-55. PubMed ID: 12639928
[TBL] [Abstract][Full Text] [Related]
20. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
